Gastrointestinal
News on in vitro diagnostics for gastrointestinal disease.
C4X Discovery to Use Genetic Signature to Predict IBD Treatment Response in Clinical Trials
The company recently discovered this gene signature in a large dataset of patients treated with a marketed a4β7 integrin antibody for ulcerative colitis.
Wellcome Sanger Institute, Open Targets Fund Inflammatory Bowel Disease Biomarker Study
Researchers will analyze multiomic and clinical data from 1,000 patients with IBD recruited from seven participating hospitals in the UK.
RCSI researchers have found a set of genes that are highly expressed in ulcerative colitis patients who progress to further stages of the disease that they hope to use in a diagnostic test.
Despite Frontline Benefit in Trial, GI Oncologists Want Better Way to Select Patients for Lutathera
Premium
NETTER-2 demonstrated the benefit of the targeted radioligand in frontline gastroenteropancreatic neuroendocrine tumors, but biomarker questions remain.
Alimentiv, AcelaBio, PharmaNest Partner to Find New NASH/MASH Biomarkers
The collaboration aims to help clinical trial sponsors understand drug effects and disease biology through spatial biology-based analyses.